Overview

Study of Potential CYP3A4 Induction by INDV-2000 in Healthy Adults

Status:
Not yet recruiting
Trial end date:
2023-08-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the potential for cytochrome P450 (CYP) 3A4 induction after dosing with INDV-2000 via use of midazolam as a probe.
Phase:
Phase 1
Details
Lead Sponsor:
Indivior Inc.
Treatments:
Midazolam